المؤلفون: Lucie Sramkova, Vaskar Saha, Christiane Chen-Santel, Anthony V. Moorman, Andishe Attarbaschi, Renate Kirschner-Schwabe, Stefanie Groeneveld-Krentz, Shekhar Krishnan, Arend von Stackelberg, Peter M. Hoogerbrugge, Martin Zimmermann, Guenter Henze, Catriona Parker, Jean-Pierre Bourquin, Tamas Revesz, Rosemary Sutton, Jeremy Hancock, Cornelia Eckert, Julie Ae Irving

المساهمون: University of Zurich, Eckert, Cornelia, Saha, Vaskar

المصدر: Eckert, C, Parker, C, Moorman, A V, Irving, J A, Kirschner-Schwabe, R, Groeneveld-Krentz, S, Révész, T, Hoogerbrugge, P, Hancock, J, Sutton, R, Henze, G, Chen-Santel, C, Attarbaschi, A, Bourquin, J-P, Sramkova, L, Zimmermann, M, Krishnan, S, von Stackelberg, A & Saha, V 2021, ' Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials ', European Journal of Cancer, vol. 151, pp. 175-189 . https://doi.org/10.1016/j.ejca.2021.03.034Test

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, Neoplasm, Residual, Time Factors, medicine.medical_treatment, High-risk, Gene Dosage, Graft vs Host Disease, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Targeted therapy, 0302 clinical medicine, Recurrence, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, Child, Clinical Trials as Topic, Manchester Cancer Research Centre, Acute lymphoblastic leukaemia, Hematopoietic Stem Cell Transplantation, Stem cell transplantation, Progression-Free Survival, medicine.anatomical_structure, Child, Preschool, 030220 oncology & carcinogenesis, Disease Progression, 2730 Oncology, Female, medicine.medical_specialty, Adolescent, T cell, Karyotype, 610 Medicine & health, Outcomes, Risk Assessment, Disease-Free Survival, 03 medical and health sciences, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Internal medicine, Biomarkers, Tumor, medicine, Humans, B cell, Proportional hazards model, business.industry, Minimal residual disease, ResearchInstitutes_Networks_Beacons/mcrc, Transplantation, Clinical trial, 030104 developmental biology, 10036 Medical Clinic, Mutation, Lymphoblastic leukaemia, business

وصف الملف: application/pdf; PIIS095980492100201X.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::704d729c17931425043d5d11dbce2418Test
https://doi.org/10.1016/j.ejca.2021.03.034Test

المؤلفون: Melchior Lauten, Georg Mann, Shai Izraeli, Jana Lentes, Martin Zimmermann, Martin Stanulla, Grazia Fazio, Barbara Buldini, Tamas Revesz, Rosemary Sutton, Marketa Zaliova, Andishe Attarbaschi, Anja Moericke, Nicole Bodmer, Sarah Elitzur, Maria Grazia Valsecchi, Brigitte Schlegelberger, Nira Arad-Cohen, Denis M. Schewe, Martin Schrappe, Gudrun Göhring, Gunnar Cario, Franco Locatelli, Oskar A. Haas, Valentino Conter, Lucie Sramkova, Veronica Leoni, Andrea Biondi, Giovanni Cazzaniga, Anke K. Bergmann, Jan Zuna, Deborah L. White, Giuseppe Basso, Swantje Buchmann, Doris Steinemann

المساهمون: Cario, G, Leoni, V, Conter, V, Attarbaschi, A, Zaliova, M, Sramkova, L, Cazzaniga, G, Fazio, G, Sutton, R, Elitzur, S, Izraeli, S, Lauten, M, Locatelli, F, Basso, G, Buldini, B, Bergmann, A, Lentes, J, Steinemann, D, Göhring, G, Schlegelberger, B, Haas, O, Schewe, D, Buchmann, S, Moericke, A, White, D, Revesz, T, Stanulla, M, Mann, G, Bodmer, N, Arad-Cohen, N, Zuna, J, Valsecchi, M, Zimmermann, M, Schrappe, M, Biondi, A

المصدر: Haematologica

مصطلحات موضوعية: Oncology, medicine.medical_specialty, ABL-class fusion, medicine.drug_class, medicine.medical_treatment, Fusion Proteins, bcr-abl, antineoplastic combined chemotherapy protocols, B-lymphocytes, child, Hematopoietic stem cell transplantation, Tyrosine-kinase inhibitor, Recurrence, Internal medicine, hemic and lymphatic diseases, medicine, Humans, Cumulative incidence, Pediatric Acute Lymphoblastic Leukemia, Child, Chemotherapy, B-Lymphocytes, ABL, business.industry, Hematology, Articles, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Lymphoblastic Leukemia, Prognosis, Tyrosin Kinase Inhibitors, Minimal residual disease, Transplantation, Settore MED/38 - PEDIATRIA GENERALE E SPECIALISTICA, Stem cell, business, ALL

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b40a393e592341af6a466b31ee735aaTest
http://hdl.handle.net/10281/270087Test

المؤلفون: Günter Henze, Christina Peters, Renate Panzer-Grümayer, Kathy Astrahantseff, Cornelia Eckert, Gunnar Cario, Nikola Hagedorn, Julia Alten, K Seeger, Lucie Sramkova, G Escherich, J-P Bourquin, Georg Mann, T. Klingebiel, A von Stackelberg, Arndt Borkhardt

المساهمون: University of Zurich, Eckert, C

المصدر: Leukemia. 29(8)

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Neoplasm, Residual, Adolescent, medicine.medical_treatment, 2720 Hematology, 610 Medicine & health, Hematopoietic stem cell transplantation, Risk Factors, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, 1306 Cancer Research, Prospective Studies, Prospective cohort study, Child, Survival rate, Monitoring, Physiologic, Neoplasm Staging, Hematology, business.industry, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Induction Chemotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Prognosis, Minimal residual disease, Lymphoma, Surgery, Survival Rate, Leukemia, Oncology, 10036 Medical Clinic, 2730 Oncology, Female, Neoplasm Recurrence, Local, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a72c27cd16c5bb580814007dd2dc56Test
https://pubmed.ncbi.nlm.nih.gov/25748682Test

المؤلفون: Felix Niggli, Karlheinz Seeger, André Schrauder, Johann Hitzler, Cornelia Eckert, Thomas Klingebiel, Arndt Borkhardt, Lucie Sramkova, Georg Mann, Renate Panzer-Grümayer, Martin Schrappe, Günter Henze, Nikola Hagedorn, Christina Peters, Gabriele Escherich, Arend von Stackelberg

المساهمون: University of Zurich, Eckert, Cornelia

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Neoplasm, Residual, medicine.medical_treatment, 610 Medicine & health, Hematopoietic stem cell transplantation, Disease-Free Survival, Recurrence, Risk Factors, hemic and lymphatic diseases, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Neoplasm, Humans, Transplantation, Homologous, 1306 Cancer Research, Child, Chemotherapy, business.industry, Hematopoietic Stem Cell Transplantation, Induction chemotherapy, Induction Chemotherapy, Precursor Cell Lymphoblastic Leukemia-Lymphoma, medicine.disease, Minimal residual disease, Combined Modality Therapy, Transplantation, Haematopoiesis, Treatment Outcome, 10036 Medical Clinic, Child, Preschool, Immunology, Female, 2730 Oncology, business, Minimal Residual Disease Response

وصف الملف: Use_of_allogeneic_stem_cell_transplantation.pdf - application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9d30b5b88ab05e44f28f7c4122397e3Test
https://www.zora.uzh.ch/id/eprint/84395Test/